CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) Additional Paid-In Capital : $55 Mil(As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is CSPC Pharmaceutical Group Additional Paid-In Capital?

CSPC Pharmaceutical Group's quarterly additional paid-in capital declined from Jun. 2023 ($41 Mil) to Sep. 2023 ($0 Mil) but then increased from Sep. 2023 ($0 Mil) to Dec. 2023 ($55 Mil).

CSPC Pharmaceutical Group's annual additional paid-in capital increased from Dec. 2021 ($7 Mil) to Dec. 2022 ($28 Mil) and increased from Dec. 2022 ($28 Mil) to Dec. 2023 ($55 Mil).

CSPC Pharmaceutical Group Additional Paid-In Capital Historical Data

The historical data trend for CSPC Pharmaceutical Group's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Additional Paid-In Capital Chart

CSPC Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

7.35

28.20

54.69

CSPC Pharmaceutical Group Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															28.20	-	40.61	-	54.69

CSPC Pharmaceutical Group Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

CSPC Pharmaceutical Group Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (OTCPK:CHJTF) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

CSPCY:USA 01093:Hong Kong CVG:Germany

Address

No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035

Website

https://www.cspc.com.hk

CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) Headlines

From GuruFocus

Value Partners Classic Fund Comments on CSPC Pharmaceutical

By Vera Yuan Vera Yuan • 07-29-2014